COVID‐19 and pediatric pulmonology: Feedback from an expert center after the first year of the pandemic

Abstract

The coronavirus disease 2019 (COVID‐19) outbreak has evolved with different waves corresponding to subsequent severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) mutations. While the most severe cases have been observed in the elderly and in individuals with underlying comorbidities, severe pediatric and young adult cases have been observed, as well as post‐infectious inflammatory syndromes and persistent symptoms leading to long‐COVID. This manuscript describes the experience of a pediatric respiratory unit during the first year of the pandemic and reviews the corresponding literature with a special emphasis on children and young people with underlying conditions, such as immunosuppression, sickle cell disease, and cystic fibrosis.

Spontaneous pneumomediastinum: A complication of SARS‐CoV‐2 variant delta infection in children

“…The delta variant is known for its high transmissibility and capacity to induce severe illness. 6 These observations raise the possibility of an association between SPM in children and this particular SARS-CoV-2 variant.…”